ARTELO BIOSCIENCES, INC. Deferred Costs, Noncurrent
ARTELO BIOSCIENCES, INC. (ARTL) had Deferred Costs, Noncurrent of $424.00 thousand as of 2025-03-31, per its 10-Q filed 2025-05-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredCosts · last filed 2025-05-13
- 2025-03-31: Deferred Costs, Noncurrent $424.00K.
- 2024-12-31: Deferred Costs, Noncurrent $0.00.
- 2022-06-30: Deferred Costs, Noncurrent $134.00K.
- 2021-12-31: Deferred Costs, Noncurrent $0.00.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2025-03-31 | $424.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $0.00 10-Q · filed 2025-05-13 |
| 2022-06-30 | $134.00K 10-Q · filed 2022-08-09 |
| 2021-12-31 | $0.00 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |